Description

The Vice President, Clinical Research will serve as a senior leader within Clinical Development, responsible for early-stage, Phase 1 and Phase 1/2 studies at Sironax. Based in Beijing, this position provides scientific, medical, and operational leadership with the design, execution, and analysis of first-in-human and proof-of-concept studies conducted globally. This executive will play a critical role in translating preclinical discoveries into early clinical candidates, driving data-driven decision-making to inform later-stage development. The VP, Clinical Research will work closely with Global Clinical Development, Regulatory, Pharmacovigilance, and Translational Science teams to ensure scientific excellence, regulatory compliance, and operational efficiency in Sironax’s early development pipeline.

Requirements

MD, MD/PhD, or equivalent clinical degree required; board certification in internal medicine, neurology, pharmacology, or related discipline preferred. Minimum 12 years of clinical development experience in the biopharmaceutical industry, including at least 8 years in early clinical development (Phase 1/2). Proven leadership experience directing FIH and early proof-of-concept studies, including global and China-based clinical trials. Strong understanding of drug development regulations and ethics in both China (NMPA) and global regulatory frameworks (FDA, EMA, ICH-GCP). Experience in neurodegenerative disease or inflammation-related therapeutic areas preferred. Deep expertise in early-phase study design, dose-escalation methodologies, PK/PD modeling, and safety data interpretation. Strong operational and medical oversight skills with a proven record of delivering high-quality studies on time.